Sureda, Anna, Chabannon, Christian ORCID: 0000-0002-3755-4889, Masszi, Tamas, Pohlreich, David, Scheid, Christof, Thieblemont, Catherine ORCID: 0000-0002-9941-2448, Wahlin, Bjorn E., Sakellari, Ioanna, Russell, Nigel, Janikova, Andrea, Dabrowska-Iwanicka, Anna ORCID: 0000-0001-8986-0397, Touzeau, Cyrille ORCID: 0000-0003-0275-2575, Esquirol, Albert, Jantunen, Esa, van der Werf, Steffie, Bosman, Paul, Boumendil, Ariane ORCID: 0000-0002-2552-0542, Liu, Qianying, Celanovic, Marina, Montoto, Silvia and Dreger, Peter (2020). Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor. Bone Marrow Transplant., 55 (3). S. 613 - 623. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

Full text not available from this repository.

Abstract

Plerixafor + granulocyte-colony stimulating factor (G-CSF) is administered to patients with lymphoma who are poor mobilizers of hematopoietic stem cells (HSCs) in Europe. This international, multicenter, non-interventional registry study (NCT01362972) evaluated long-term follow-up of patients with lymphoma who received plerixafor for HSC mobilization versus other mobilization methods. Propensity score matching was conducted to balance baseline characteristics between comparison groups. The following mobilization regimens were compared: G-CSF + plerixafor (G + P) versus G-CSF alone; G + P versus G-CSF + chemotherapy (G + C); and G-CSF + plerixafor + chemotherapy (G + P + C) versus G + C. The primary outcomes were progression-free survival (PFS), overall survival (OS), and cumulative incidence of relapse (CIR). Overall, 313/3749 (8.3%) eligible patients were mobilized with plerixafor-containing regimens. After propensity score matching, 70 versus 36 patients were matched in the G + P versus G-CSF alone cohort, 124 versus 124 in the G + P versus G + C cohort, and 130 versus 130 in the G + P + C versus G + C cohort. For both PFS and OS, the upper bound of confidence interval for the hazard ratio was >1.3 for all comparisons, implying that non-inferiority was not demonstrated. No major differences in PFS, OS, and CIR were observed between the plerixafor and comparison groups.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Sureda, AnnaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Chabannon, ChristianUNSPECIFIEDorcid.org/0000-0002-3755-4889UNSPECIFIED
Masszi, TamasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Pohlreich, DavidUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Scheid, ChristofUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Thieblemont, CatherineUNSPECIFIEDorcid.org/0000-0002-9941-2448UNSPECIFIED
Wahlin, Bjorn E.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Sakellari, IoannaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Russell, NigelUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Janikova, AndreaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Dabrowska-Iwanicka, AnnaUNSPECIFIEDorcid.org/0000-0001-8986-0397UNSPECIFIED
Touzeau, CyrilleUNSPECIFIEDorcid.org/0000-0003-0275-2575UNSPECIFIED
Esquirol, AlbertUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Jantunen, EsaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
van der Werf, SteffieUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bosman, PaulUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Boumendil, ArianeUNSPECIFIEDorcid.org/0000-0002-2552-0542UNSPECIFIED
Liu, QianyingUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Celanovic, MarinaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Montoto, SilviaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Dreger, PeterUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-342863
DOI: 10.1038/s41409-019-0693-z
Journal or Publication Title: Bone Marrow Transplant.
Volume: 55
Number: 3
Page Range: S. 613 - 623
Date: 2020
Publisher: NATURE PUBLISHING GROUP
Place of Publication: LONDON
ISSN: 1476-5365
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
STEM-CELL MOBILIZATION; MULTIPLE-MYELOMA; CHEMOKINE RECEPTOR; POOR MOBILIZATION; AMD3100Multiple languages
Biophysics; Oncology; Hematology; Immunology; TransplantationMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/34286

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item